Pfizer Inc. plans to cut 270 jobs at its Brooklyn manufacturing plant in anticipation of lower sales for several drugs that are made there. The Brooklyn plant employs 990.
Join our WhatsApp groupSubscribe to our Daily Roundup Email
The reductions at the Brooklyn plant span a range of manufacturing jobs, Diflucan, Zithromax, Zoloft, Norvasc and Zyrtec are among products that have lost or will lose patent exclusivity, so several of this products are going off patent so they expect to see volumes decline.
Brooklyn Borough President Marty Markowitz said he was saddened by the layoffs but optimistic about the future. “The good news is that the Brooklyn facility continues to be open and it is my hope that in the days ahead new drugs will be discovered that will be appropriate for the Brooklyn plant to produce,” he said in an emailed statement.